Evolution of the NCCN Guidelines for Kidney Cancer -Tian Zhang

Tian Zhang and Charles Ryan highlight recent updates in the NCCN treatment guidelines for kidney cancer resulting from data leading to changes in treatment options. Incorporation of initial diagnosis, disease biology, risk category, and clinical factors assist with selecting the most appropriate therapy for these patients.11/21/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news